Bank of America’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-212
Closed -$48 7426
2024
Q4
$48 Sell
212
-493
-70% -$112 ﹤0.01% 6946
2024
Q3
$1.52K Sell
705
-17,419
-96% -$37.5K ﹤0.01% 6242
2024
Q2
$93.5K Sell
18,124
-15,618
-46% -$80.6K ﹤0.01% 5443
2024
Q1
$181K Buy
33,742
+23,721
+237% +$127K ﹤0.01% 5095
2023
Q4
$78.1K Buy
10,021
+9,953
+14,637% +$77.5K ﹤0.01% 5550
2023
Q3
$269 Sell
68
-1
-1% -$4 ﹤0.01% 6447
2023
Q2
$218 Sell
69
-1,046
-94% -$3.31K ﹤0.01% 6485
2023
Q1
$2.98K Sell
1,115
-34
-3% -$91 ﹤0.01% 6338
2022
Q4
$4.13K Sell
1,149
-7
-0.6% -$25 ﹤0.01% 6272
2022
Q3
$7K Sell
1,156
-1,295
-53% -$7.84K ﹤0.01% 6446
2022
Q2
$24K Sell
2,451
-355
-13% -$3.48K ﹤0.01% 6316
2022
Q1
$34K Sell
2,806
-1,444
-34% -$17.5K ﹤0.01% 6529
2021
Q4
$139K Buy
4,250
+1,136
+36% +$37.2K ﹤0.01% 5886
2021
Q3
$139K Sell
3,114
-187
-6% -$8.35K ﹤0.01% 5679
2021
Q2
$180K Sell
3,301
-828
-20% -$45.2K ﹤0.01% 5394
2021
Q1
$309K Buy
4,129
+2,718
+193% +$203K ﹤0.01% 5091
2020
Q4
$153K Sell
1,411
-4,138
-75% -$449K ﹤0.01% 5040
2020
Q3
$491K Buy
5,549
+3,660
+194% +$324K ﹤0.01% 4177
2020
Q2
$202K Sell
1,889
-261
-12% -$27.9K ﹤0.01% 4699
2020
Q1
$128K Buy
2,150
+642
+43% +$38.2K ﹤0.01% 4808
2019
Q4
$104K Buy
1,508
+136
+10% +$9.38K ﹤0.01% 5174
2019
Q3
$142K Buy
1,372
+569
+71% +$58.9K ﹤0.01% 5066
2019
Q2
$75K Buy
803
+50
+7% +$4.67K ﹤0.01% 5358
2019
Q1
$69K Sell
753
-987
-57% -$90.4K ﹤0.01% 5305
2018
Q4
$98K Buy
1,740
+1,171
+206% +$66K ﹤0.01% 5194
2018
Q3
$68K Buy
569
+200
+54% +$23.9K ﹤0.01% 5339
2018
Q2
$38K Buy
369
+248
+205% +$25.5K ﹤0.01% 5540
2018
Q1
$16K Sell
121
-28
-19% -$3.7K ﹤0.01% 5714
2017
Q4
$14K Buy
149
+77
+107% +$7.24K ﹤0.01% 5707
2017
Q3
$11K Buy
72
+41
+132% +$6.26K ﹤0.01% 5708
2017
Q2
$5K Sell
31
-51
-62% -$8.23K ﹤0.01% 5819
2017
Q1
$13K Buy
82
+18
+28% +$2.85K ﹤0.01% 5710
2016
Q4
$8K Buy
+64
New +$8K ﹤0.01% 5820